anthracene has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brouwer, J; Contaldi, S; den Dulk, H; Jaehde, U; Kalayda, GV; Marqués-Gallego, P; Monari, M; Reedijk, J | 1 |
1 other study(ies) available for anthracene and Carcinoma
| Article | Year |
|---|---|
Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Topics: Anthracenes; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Crystallography, X-Ray; Female; Humans; Ligands; Organoplatinum Compounds; Ovarian Neoplasms | 2009 |